<inf:proxyVoteTable xmlns:inf="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <inf:proxyTable>
  <inf:issuerName>AbbVie Inc.</inf:issuerName>
  <inf:cusip>00287Y109</inf:cusip>
  <inf:meetingDate>05/08/2026</inf:meetingDate>
  <inf:voteDescription>Say on pay - an advisory vote on the approval of executive compensation</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>30102.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>30102.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>ADC Therapeutics SA</inf:issuerName>
  <inf:cusip>H0036K147</inf:cusip>
  <inf:meetingDate>06/01/2026</inf:meetingDate>
  <inf:voteDescription>Approving, on an advisory basis under U.S. law, the compensation paid to our Named Executive Officers. The Board of Directors proposes that the following proposal: RESOLVED, that the Company's Shareholders approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in Executive Compensation and the related compensation tables and narrative disclosure in this proxy statement, be approved.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>934491.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>934491.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Adobe Inc.</inf:issuerName>
  <inf:cusip>00724F101</inf:cusip>
  <inf:meetingDate>04/15/2026</inf:meetingDate>
  <inf:voteDescription>Approve, on an advisory basis, the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>13908.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>13908.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Advanced Micro Devices, Inc.</inf:issuerName>
  <inf:cusip>007903107</inf:cusip>
  <inf:meetingDate>05/13/2026</inf:meetingDate>
  <inf:voteDescription>Approve on a non-binding advisory basis the compensation of the named executive officers, as disclosed in the proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>7210.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>7210.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Alphabet Inc.</inf:issuerName>
  <inf:cusip>02079K305</inf:cusip>
  <inf:meetingDate>06/05/2026</inf:meetingDate>
  <inf:voteDescription>Advisory vote to approve compensation awarded to named executive officers</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>12000.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>12000.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Amphenol Corporation</inf:issuerName>
  <inf:cusip>032095101</inf:cusip>
  <inf:meetingDate>05/21/2026</inf:meetingDate>
  <inf:voteDescription>Advisory Vote to Approve Compensation of Named Executive Officers</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>9440.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>9440.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Apogee Therapeutics, Inc.</inf:issuerName>
  <inf:cusip>03770N101</inf:cusip>
  <inf:meetingDate>06/09/2026</inf:meetingDate>
  <inf:voteDescription>Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>58314.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>58314.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Arcus Biosciences, Inc.</inf:issuerName>
  <inf:cusip>03969F109</inf:cusip>
  <inf:meetingDate>06/11/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>134217.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>134217.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Arrowhead Pharmaceuticals, Inc.</inf:issuerName>
  <inf:cusip>04280A100</inf:cusip>
  <inf:meetingDate>03/19/2026</inf:meetingDate>
  <inf:voteDescription>Advisory Vote to Approve Executive Compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>80082.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>80082.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Bicycle Therapeutics plc</inf:issuerName>
  <inf:cusip>088786108</inf:cusip>
  <inf:meetingDate>06/17/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>184603.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>184603.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Booking Holdings Inc.</inf:issuerName>
  <inf:cusip>09857L108</inf:cusip>
  <inf:meetingDate>06/02/2026</inf:meetingDate>
  <inf:voteDescription>Advisory vote to approve 2025 executive compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>12500.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>12500.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
  <inf:cusip>101137107</inf:cusip>
  <inf:meetingDate>04/30/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>25203.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>25203.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Broadcom Inc.</inf:issuerName>
  <inf:cusip>11135F101</inf:cusip>
  <inf:meetingDate>04/20/2026</inf:meetingDate>
  <inf:voteDescription>Advisory vote to approve the named executive officer compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>30874.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>AGAINST</inf:howVoted>
      <inf:sharesVoted>30874.0</inf:sharesVoted>
      <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Codexis, Inc.</inf:issuerName>
  <inf:cusip>192005106</inf:cusip>
  <inf:meetingDate>06/17/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>264464.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>264464.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Cogent Biosciences, Inc.</inf:issuerName>
  <inf:cusip>19240Q201</inf:cusip>
  <inf:meetingDate>06/09/2026</inf:meetingDate>
  <inf:voteDescription>Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>123730.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>123730.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Dow Inc.</inf:issuerName>
  <inf:cusip>260557103</inf:cusip>
  <inf:meetingDate>04/09/2026</inf:meetingDate>
  <inf:voteDescription>Advisory Resolution to Approve Executive Compensation</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>2408.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>2408.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Dow Inc.</inf:issuerName>
  <inf:cusip>260557103</inf:cusip>
  <inf:meetingDate>04/09/2026</inf:meetingDate>
  <inf:voteDescription>Advisory Resolution on the Frequency of Future Advisory Votes to Approve Executive Compensation</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>2408.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>1 YEAR</inf:howVoted>
      <inf:sharesVoted>2408.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Dutch Bros Inc.</inf:issuerName>
  <inf:cusip>26701L100</inf:cusip>
  <inf:meetingDate>05/13/2026</inf:meetingDate>
  <inf:voteDescription>Approval, on a Non-Binding, Advisory Basis, of the Compensation of our Named Executive Officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>50000.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>50000.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>e.l.f. Beauty, Inc.</inf:issuerName>
  <inf:cusip>26856L103</inf:cusip>
  <inf:meetingDate>08/21/2025</inf:meetingDate>
  <inf:voteDescription>To approve, on an advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>40000.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>40000.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Fair Isaac Corporation</inf:issuerName>
  <inf:cusip>303250104</inf:cusip>
  <inf:meetingDate>03/04/2026</inf:meetingDate>
  <inf:voteDescription>To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the proxy statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>3859.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>3859.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Floor &amp; Decor Holdings, Inc.</inf:issuerName>
  <inf:cusip>339750101</inf:cusip>
  <inf:meetingDate>05/06/2026</inf:meetingDate>
  <inf:voteDescription>Approve, by non-binding vote, the compensation paid to the Company's named executive officers for the 2025 fiscal year.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>65000.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>65000.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>GE Vernova Inc.</inf:issuerName>
  <inf:cusip>36828A101</inf:cusip>
  <inf:meetingDate>05/20/2026</inf:meetingDate>
  <inf:voteDescription>Approve the compensation of our named executive officers in an advisory vote</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>3047.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>3047.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>General Mills, Inc.</inf:issuerName>
  <inf:cusip>370334104</inf:cusip>
  <inf:meetingDate>09/30/2025</inf:meetingDate>
  <inf:voteDescription>Advisory Vote on Executive Compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>5493.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>5493.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Globalstar, Inc.</inf:issuerName>
  <inf:cusip>378973507</inf:cusip>
  <inf:meetingDate>05/13/2026</inf:meetingDate>
  <inf:voteDescription>Approve, on an advisory basis, the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>14168.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>14168.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>HP Inc.</inf:issuerName>
  <inf:cusip>40434L105</inf:cusip>
  <inf:meetingDate>04/16/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on an advisory basis, HP Inc.'s named executive officer compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>3264.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>3264.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>IDEAYA Biosciences, Inc.</inf:issuerName>
  <inf:cusip>45166A102</inf:cusip>
  <inf:meetingDate>06/16/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>91637.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>91637.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>IDEXX Laboratories, Inc.</inf:issuerName>
  <inf:cusip>45168D104</inf:cusip>
  <inf:meetingDate>05/12/2026</inf:meetingDate>
  <inf:voteDescription>Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>3000.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>3000.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Immunovant, Inc.</inf:issuerName>
  <inf:cusip>45258J102</inf:cusip>
  <inf:meetingDate>08/27/2025</inf:meetingDate>
  <inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>195727.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>195727.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Intercontinental Exchange, Inc.</inf:issuerName>
  <inf:cusip>45866F104</inf:cusip>
  <inf:meetingDate>05/15/2026</inf:meetingDate>
  <inf:voteDescription>To approve, by non-binding vote, the advisory resolution on executive compensation for named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>23913.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>23913.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
  <inf:cusip>46120E602</inf:cusip>
  <inf:meetingDate>04/30/2026</inf:meetingDate>
  <inf:voteDescription>To approve, by advisory vote, the compensation of the Company's Named Executive Officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>4846.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>4846.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>IQVIA Holdings Inc.</inf:issuerName>
  <inf:cusip>46266C105</inf:cusip>
  <inf:meetingDate>04/23/2026</inf:meetingDate>
  <inf:voteDescription>Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay).</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>26708.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>AGAINST</inf:howVoted>
      <inf:sharesVoted>26708.0</inf:sharesVoted>
      <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Jazz Pharmaceuticals Public Limited Company</inf:issuerName>
  <inf:cusip>G50871105</inf:cusip>
  <inf:meetingDate>07/24/2025</inf:meetingDate>
  <inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>2355.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>2355.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
  <inf:cusip>478160104</inf:cusip>
  <inf:meetingDate>04/23/2026</inf:meetingDate>
  <inf:voteDescription>Advisory Vote to Approve Named Executive Officer Compensation</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>27830.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>27830.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>KLA Corporation</inf:issuerName>
  <inf:cusip>482480100</inf:cusip>
  <inf:meetingDate>11/05/2025</inf:meetingDate>
  <inf:voteDescription>To approve on a non-binding, advisory basis our named executive officer compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>2199.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>2199.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Kyndryl Holdings, Inc.</inf:issuerName>
  <inf:cusip>50155Q100</inf:cusip>
  <inf:meetingDate>07/31/2025</inf:meetingDate>
  <inf:voteDescription>Approval, in an advisory, non-binding vote, of the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>205.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>205.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Lam Research Corporation</inf:issuerName>
  <inf:cusip>512807306</inf:cusip>
  <inf:meetingDate>11/04/2025</inf:meetingDate>
  <inf:voteDescription>Advisory vote to approve the compensation of the named executive officers ("Say on Pay")</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>157997.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>157997.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
  <inf:cusip>58933Y105</inf:cusip>
  <inf:meetingDate>05/26/2026</inf:meetingDate>
  <inf:voteDescription>Non-binding advisory vote to approve the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>63316.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>63316.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Microchip Technology Incorporated</inf:issuerName>
  <inf:cusip>595017104</inf:cusip>
  <inf:meetingDate>08/19/2025</inf:meetingDate>
  <inf:voteDescription>Proposal to approve, on an advisory (non-binding) basis, the compensation of our named executives.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>9296.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>9296.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Micron Technology, Inc.</inf:issuerName>
  <inf:cusip>595112103</inf:cusip>
  <inf:meetingDate>01/15/2026</inf:meetingDate>
  <inf:voteDescription>Proposal By The Company To Approve, On A Non-Binding Advisory Basis, The Compensation Of Our Named Executive Officers As Described In The Proxy Statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>56927.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>56927.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Microsoft Corporation</inf:issuerName>
  <inf:cusip>594918104</inf:cusip>
  <inf:meetingDate>12/05/2025</inf:meetingDate>
  <inf:voteDescription>Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote")</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>8573.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>8573.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Motorola Solutions, Inc.</inf:issuerName>
  <inf:cusip>620076307</inf:cusip>
  <inf:meetingDate>05/18/2026</inf:meetingDate>
  <inf:voteDescription>Advisory approval of the Company's executive compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>6302.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>6302.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Netflix, Inc.</inf:issuerName>
  <inf:cusip>64110L106</inf:cusip>
  <inf:meetingDate>06/04/2026</inf:meetingDate>
  <inf:voteDescription>Advisory approval of named executive officer compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>50023.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>50023.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Palisade Bio, Inc.</inf:issuerName>
  <inf:cusip>696389402</inf:cusip>
  <inf:meetingDate>06/10/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>1231414.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>ABSTAIN</inf:howVoted>
      <inf:sharesVoted>1231414.0</inf:sharesVoted>
      <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Roivant Sciences Ltd.</inf:issuerName>
  <inf:cusip>G76279101</inf:cusip>
  <inf:meetingDate>09/10/2025</inf:meetingDate>
  <inf:voteDescription>To cast a non-binding, advisory vote to approve the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>481335.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>481335.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Skye Bioscience, Inc.</inf:issuerName>
  <inf:cusip>83086J200</inf:cusip>
  <inf:meetingDate>05/26/2026</inf:meetingDate>
  <inf:voteDescription>Consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in the accompanying proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>233095.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>233095.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Stoke Therapeutics, Inc</inf:issuerName>
  <inf:cusip>86150R107</inf:cusip>
  <inf:meetingDate>06/03/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on an advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>40815.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>40815.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Structure Therapeutics Inc.</inf:issuerName>
  <inf:cusip>86366E106</inf:cusip>
  <inf:meetingDate>06/17/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>66864.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>66864.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>The Cigna Group</inf:issuerName>
  <inf:cusip>125523100</inf:cusip>
  <inf:meetingDate>04/22/2026</inf:meetingDate>
  <inf:voteDescription>Advisory approval of executive compensation</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>273.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>273.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>The Goodyear Tire &amp; Rubber Company</inf:issuerName>
  <inf:cusip>382550101</inf:cusip>
  <inf:meetingDate>04/13/2026</inf:meetingDate>
  <inf:voteDescription>Advisory vote to approve executive compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>7218.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>7218.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>The Home Depot, Inc.</inf:issuerName>
  <inf:cusip>437076102</inf:cusip>
  <inf:meetingDate>05/21/2026</inf:meetingDate>
  <inf:voteDescription>Advisory Vote to Approve Executive Compensation ("Say-on-Pay")</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>11500.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>11500.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>The Kroger Co.</inf:issuerName>
  <inf:cusip>501044101</inf:cusip>
  <inf:meetingDate>06/25/2026</inf:meetingDate>
  <inf:voteDescription>Approval, on an advisory basis, of Kroger's executive compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>60743.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>60743.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>TransUnion</inf:issuerName>
  <inf:cusip>89400J107</inf:cusip>
  <inf:meetingDate>05/12/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of TransUnion's named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>44595.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>44595.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Valaris Limited</inf:issuerName>
  <inf:cusip>G9460G101</inf:cusip>
  <inf:meetingDate>06/10/2026</inf:meetingDate>
  <inf:voteDescription>To approve on a non-binding advisory basis the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>45956.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>45956.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Vera Therapeutics, Inc.</inf:issuerName>
  <inf:cusip>92337R101</inf:cusip>
  <inf:meetingDate>05/21/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>113687.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>113687.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Vertiv Holdings Co</inf:issuerName>
  <inf:cusip>92537N108</inf:cusip>
  <inf:meetingDate>06/17/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on an advisory basis, the 2025 compensation of our named executive officers as disclosed in the Proxy Statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>10127.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>10127.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Visa Inc.</inf:issuerName>
  <inf:cusip>92826C839</inf:cusip>
  <inf:meetingDate>01/27/2026</inf:meetingDate>
  <inf:voteDescription>To approve, on an advisory basis, the compensation paid to our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>14700.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>14700.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>WAVE Life Sciences Ltd.</inf:issuerName>
  <inf:cusip>Y95308105</inf:cusip>
  <inf:meetingDate>08/05/2025</inf:meetingDate>
  <inf:voteDescription>To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>355353.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>355353.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>WAVE Life Sciences Ltd.</inf:issuerName>
  <inf:cusip>Y95308105</inf:cusip>
  <inf:meetingDate>08/05/2025</inf:meetingDate>
  <inf:voteDescription>To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>355353.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>1 YEAR</inf:howVoted>
      <inf:sharesVoted>355353.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>WAVE Life Sciences Ltd.</inf:issuerName>
  <inf:cusip>Y95308105</inf:cusip>
  <inf:meetingDate>08/05/2025</inf:meetingDate>
  <inf:voteDescription>To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>302133.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>302133.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>WAVE Life Sciences Ltd.</inf:issuerName>
  <inf:cusip>Y95308105</inf:cusip>
  <inf:meetingDate>08/05/2025</inf:meetingDate>
  <inf:voteDescription>To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>302133.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>1 YEAR</inf:howVoted>
      <inf:sharesVoted>302133.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Whirlpool Corporation</inf:issuerName>
  <inf:cusip>963320106</inf:cusip>
  <inf:meetingDate>04/21/2026</inf:meetingDate>
  <inf:voteDescription>Advisory vote to approve Whirlpool Corporation's executive compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>794.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>794.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Wingstop Inc.</inf:issuerName>
  <inf:cusip>974155103</inf:cusip>
  <inf:meetingDate>05/21/2026</inf:meetingDate>
  <inf:voteDescription>Approve, on an advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>11000.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>11000.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Yum! Brands, Inc.</inf:issuerName>
  <inf:cusip>988498101</inf:cusip>
  <inf:meetingDate>05/14/2026</inf:meetingDate>
  <inf:voteDescription>Advisory Vote on Executive Compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>39847.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>39847.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Zoetis Inc.</inf:issuerName>
  <inf:cusip>98978V103</inf:cusip>
  <inf:meetingDate>05/20/2026</inf:meetingDate>
  <inf:voteDescription>Advisory vote to approve our executive compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>42000.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>42000.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Zoetis Inc.</inf:issuerName>
  <inf:cusip>98978V103</inf:cusip>
  <inf:meetingDate>05/20/2026</inf:meetingDate>
  <inf:voteDescription>Advisory vote to approve the frequency of future advisory votes on our executive compensation.</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>42000.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>1 YEAR</inf:howVoted>
      <inf:sharesVoted>42000.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
  <inf:proxyTable>
  <inf:issuerName>Zymeworks Inc.</inf:issuerName>
  <inf:cusip>98985Y108</inf:cusip>
  <inf:meetingDate>12/30/2025</inf:meetingDate>
  <inf:voteDescription>Advisory vote on the compensation of our named executive officers</inf:voteDescription>
  <inf:voteCategories>
    <inf:voteCategory>
      <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
    </inf:voteCategory>
  </inf:voteCategories>
  <inf:voteSource>ISSUER</inf:voteSource>
  <inf:sharesVoted>124784.0</inf:sharesVoted>
  <inf:sharesOnLoan>0.0</inf:sharesOnLoan>
  <inf:vote>
    <inf:voteRecord>
      <inf:howVoted>FOR</inf:howVoted>
      <inf:sharesVoted>124784.0</inf:sharesVoted>
      <inf:managementRecommendation>FOR</inf:managementRecommendation>
    </inf:voteRecord>
  </inf:vote>
</inf:proxyTable>
</inf:proxyVoteTable>
